BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34164261)

  • 1. A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients.
    Arab-Zozani M; Kheyrandish S; Rastgar A; Miri-Moghaddam E
    Ann Glob Health; 2021 Jun; 87(1):48. PubMed ID: 34164261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Koohi F; Kazemi T; Miri-Moghaddam E
    Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M; de Sanctis V; Ramzi M; Mousavi MR
    Hemoglobin; 2021 Sep; 45(5):275-286. PubMed ID: 34806533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
    Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
    Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
    Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.
    Wang CH; Wu KH; Tsai FJ; Peng CT; Tsai CH
    Hemoglobin; 2006; 30(2):257-62. PubMed ID: 16798651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
    Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
    Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients.
    Tangvarasittichai S; Pimanprom A; Choowet A; Tangvarasittichai O
    Clin Lab; 2013; 59(7-8):861-8. PubMed ID: 24133917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
    Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
    Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications and treatment of patients with β-thalassemia in France: results of the National Registry.
    Thuret I; Pondarré C; Loundou A; Steschenko D; Girot R; Bachir D; Rose C; Barlogis V; Donadieu J; de Montalembert M; Hagege I; Pegourie B; Berger C; Micheau M; Bernaudin F; Leblanc T; Lutz L; Galactéros F; Siméoni MC; Badens C
    Haematologica; 2010 May; 95(5):724-9. PubMed ID: 20007138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.
    He LN; Chen W; Yang Y; Xie YJ; Xiong ZY; Chen DY; Lu D; Liu NQ; Yang YH; Sun XF
    Biomed Res Int; 2019; 2019():6573497. PubMed ID: 31119181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine complications in patients with Thalassaemia Major.
    Toumba M; Sergis A; Kanaris C; Skordis N
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.
    Tantiworawit A; Tapanya S; Phrommintikul A; Saekho S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C; Hantrakool S; Charoenkwan P; Chattipakorn N
    Southeast Asian J Trop Med Public Health; 2016 Nov; 47(6):1335-42. PubMed ID: 29634199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.